Picture of Wave Life Sciences logo

WVE — Wave Life Sciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapSucker Stock

Wave Life Sciences Ltd Reports Results For The Quarter Ended September 30: Earnings Summary

* WAVE Life Sciences Ltd  WVE.OQ  reported a quarterly
adjusted
loss of 47 cents​​ per share for the quarter ended September 30,
lower than the same quarter last year, when the company reported
EPS of 7 cents.  The mean expectation of ten analysts for the
quarter was for a loss of 28 cents per share. Wall Street
expected results to range from -39 cents to -19 cents per share.
    * Revenue rose 115.6% to $-7.68 million from a year ago;
analysts
expected $16.95 million. 
    * WAVE Life Sciences Ltd's reported EPS for the quarter was
a loss
of 47 cents​.
    * The company reported a quarterly loss of $61.78 million.
    * WAVE Life Sciences Ltd shares had risen by 100.5% this
quarter and gained 225.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 1.3%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for WAVE Life
Sciences Ltd is 21.00 
This summary was machine generated from LSEG data November 12 at
03:34 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.28          -0.47          Missed
 Jun. 30 2024      -0.21          -0.25          Missed
 Mar. 31 2024      -0.21          -0.24          Missed
 Dec. 31 2023      -0.23          -0.15          Beat

Recent news on Wave Life Sciences

See all news